A PYMNTS Company

Winter 2008, Volume 2, Number 1

Feb-08(1) & (2)
 |  Dec 20, 2015

In this issue: The European Commission’s Sector Inquiry of Pharmaceuticals Kent Bernard, Feb 06, 2008 The EC Sector Inquiry Regarding Pharmaceuticals: Some Thoughts from a U.S. Perspective When a major…

Comment on the EC’s Pharmaceutical Dawn Raids
 |  Feb 14, 2008

This article is part of a Chronicle. See more from this Chronicle Susan Creighton, Scott Russell, Feb 14, 2008 The pharmaceutical industry remains under close examination by antitrust enforcers on…

The EC’s Sector Inquiry on Pharmaceuticals
 |  Feb 14, 2008

This article is part of a Chronicle. See more from this Chronicle Luc Gyselen, Feb 14, 2008 Since the entry into force of Regulation 1/2003 on May 1, 2004, the…

The EC’s Investigation into the Pharmaceutical Sector: Trouble Ahead at the IP/Competition Intersection?
 |  Feb 7, 2008

This article is part of a Chronicle. See more from this Chronicle David Hull, Feb 07, 2008 Efforts by innovative pharmaceutical companies to protect their markets against generic drugs have…

Non-contractual liability of the European Community in competition matters: The aftermath of the CFI judgment of 11 July 2007 in Case T-351/03, Schneider v. Commission
 |  Feb 5, 2008

This article is part of a Chronicle. See more from this Chronicle Aitor Montesa Lloreda, Feb 05, 2008 The recent European Court of First Instance (CFI) judgment of July 11,…

The EC Sector Inquiry Regarding Pharmaceuticals: Some Thoughts from a U.S. Perspective
 |  Feb 4, 2008

This article is part of a Chronicle. See more from this Chronicle Kent Bernard, Feb 06, 2008 On January 16, 2008, the European Commission launched a sector inquiry by staging…

Loading...